INTI

Inhibitor Therapeutics (QB) (INTI)

Inhibitor Therapeutics Inc (QB)

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:USOTC:INTI

1 2 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/11/12	20 : 27	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	USOTC:INTI	Inhibitor Therapeutics Inc (QB)
2024/08/06	22 : 30	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	USOTC:INTI	Inhibitor Therapeutics Inc (QB)
2024/05/17	02 : 34	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:INTI	Inhibitor Therapeutics Inc (QB)
2024/05/17	02 : 34	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:INTI	Inhibitor Therapeutics Inc (QB)
2024/05/17	02 : 34	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:INTI	Inhibitor Therapeutics Inc (QB)
2024/05/17	02 : 34	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:INTI	Inhibitor Therapeutics Inc (QB)
2024/05/17	02 : 34	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:INTI	Inhibitor Therapeutics Inc (QB)
2024/05/13	22 : 00	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	USOTC:INTI	Inhibitor Therapeutics Inc (QB)
2023/12/14	20 : 02	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:INTI	Inhibitor Therapeutics Inc (QB)
2023/10/18	22 : 54	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:INTI	Inhibitor Therapeutics Inc (QB)
2023/08/30	04 : 49	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:INTI	Inhibitor Therapeutics Inc (QB)
2023/08/30	03 : 42	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	USOTC:INTI	Inhibitor Therapeutics Inc (QB)
2023/08/30	03 : 33	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:INTI	Inhibitor Therapeutics Inc (QB)
2023/08/11	22 : 15	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	USOTC:INTI	Inhibitor Therapeutics Inc (QB)
2023/06/01	05 : 31	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:INTI	Inhibitor Therapeutics Inc (QB)
2023/05/24	01 : 50	Edgar (US Regulatory)	Statement of Beneficial Ownership (sc 13d)	USOTC:INTI	Inhibitor Therapeutics Inc (QB)
2023/05/23	04 : 45	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	USOTC:INTI	Inhibitor Therapeutics Inc (QB)
2023/05/18	19 : 02	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	USOTC:INTI	Inhibitor Therapeutics Inc (QB)
2023/05/18	08 : 47	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:INTI	Inhibitor Therapeutics Inc (QB)
2023/05/18	08 : 11	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	USOTC:INTI	Inhibitor Therapeutics Inc (QB)
2023/05/18	08 : 10	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:INTI	Inhibitor Therapeutics Inc (QB)
2023/05/15	22 : 04	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:INTI	Inhibitor Therapeutics Inc (QB)
2022/12/20	07 : 01	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:INTI	Inhibitor Therapeutics Inc (QB)
2022/11/15	06 : 39	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:INTI	Inhibitor Therapeutics Inc (QB)
2022/09/16	06 : 07	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:INTI	Inhibitor Therapeutics Inc (QB)
2022/05/13	22 : 02	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:INTI	Inhibitor Therapeutics Inc (QB)
2022/03/30	22 : 02	Edgar (US Regulatory)	Annual Report (10-k)	USOTC:INTI	Inhibitor Therapeutics Inc (QB)
2021/11/12	23 : 02	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:INTI	Inhibitor Therapeutics Inc (QB)
2021/05/14	22 : 02	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:INTI	Inhibitor Therapeutics Inc (QB)
2021/03/26	22 : 03	Edgar (US Regulatory)	Annual Report (10-k)	USOTC:INTI	Inhibitor Therapeutics Inc (QB)